How to Improve Clinical Trials by Empowering the Patient to Share their RWD and Patient-Contributed Data
In the rapidly evolving world of clinical trial technology, Debi Willis, CEO of MyPatientLink, is leading the charge in...
Moe Alsumidaie
Transforming Clinical Trials: Gen Li’s Vision for the Future
In the dynamic world of clinical trials, Gen Li of Phesi offers a unique perspective on the industry’s challenges...
Advancing Cancer Treatment with Nektar Therapeutics: Insights into NKTR-255
In this interview, we sit down with Mario Marcondes from Nektar Therapeutics to explore the advancements and potential of...
Eisai’s Innovative Bayesian Approach Accelerates Alzheimer’s Drug Approval
At the DPHARM conference, Eisai Inc. showcased their groundbreaking use of Bayesian methods to achieve accelerated approval for their...
Transforming Clinical Trials: ActiGraph’s Strategic Acquisition
In this conversation with Christine Guo, Chief Scientific Officer at ActiGraph, we explored the impact of Actigraph’s acquisition of...
Exploring Innovations in Muscle Wasting Disease Treatment
In this interview, we engage with David Craig from Sarcomatrix Therapeutics to discuss the development of S-969, a novel...
Emervax’s Circular RNA: A New Frontier in Vaccine Development
In this interview, we speak with Peter Weinstein, co-founder of Emervax. The discussion delves into Emervax’s innovative circular RNA...
Navigating Digital Health and Clinical Trials in Saudi Arabia
In this Q&A, we interview Dr. Tamara Sunbul, a digital health clinical trial leader. Dr. Sunbul discusses the regulatory...
Abbott’s Roadmap to Diversifying Clinical Trials
In this interview, Jennifer Jones-McMeans, Ph.D., co-leader of Abbott’s Diversity in Research Office and divisional vice president of global...
FDA Update on ICH E6, E8, QbD and RBM in Clinical Trials
The recent FDA workshop, “Building Quality into the Design and Conduct of Clinical Studies: Integrating Quality by Design (QbD)...